Measurement of Infect, Bld Rev Transcrp Quan PCR, New Tech 8

This code describes a laboratory procedure that detects and quantifies specific RNA sequences in a whole blood sample to identify and measure the presence of infectious agents. It utilizes reverse transcription to convert RNA to DNA, followed by real-time polymerase chain reaction (PCR) to amplify and measure the target DNA, providing a precise assessment of infection. This is a novel technology for infection measurement.

This code is applicable when a physician orders a whole blood test using reverse transcription and quantitative real-time PCR to diagnose or monitor an infection. This may be used for identifying viral infections, bacterial infections, or other pathogens where RNA detection and quantification are crucial for patient management. It is particularly relevant for new or emerging infectious disease diagnostics.

• Ensure the documentation specifically states "whole blood" as the specimen type and "reverse transcription and quantitative real-time PCR" as the methodology.
• Verify that the procedure is performed for the measurement of an infection, not for genetic testing or other non-infectious applications.
• Confirm that this specific "New Technology Group 8" is documented or implied by the technology used, as other PCR-based infection measurements exist.